Stay updated on Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe study page now shows a 403 Forbidden error with a minimal header and a Home link, replacing the previous detailed study content and sections.SummaryDifference21%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.6.6 replaces the previous v3.6.5 on the page, indicating a small update to the documentation. It does not alter study content or page functionality.SummaryDifference0.0%

- Check29 days agoChange DetectedThe page now includes an additional funding identifier indicating a U.S. NIH grant/contract for the study in 2016.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, indicating a minor patch to the page's documentation. This does not reflect a substantive change to content or features.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page updated its revision label from v3.6.3 to v3.6.4, reflecting a new build/version in the site metadata. This change represents a minor update to the page's underlying versioning information rather than any user-facing content.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3, indicating a newer published revision of the page. This reflects a minor update to the page rather than changes to the study content.SummaryDifference0.0%

Stay in the know with updates to Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.